Biopsy Devices Market Scope And Analysis

Report Code : TIPHE100001402
Category : Life Sciences

No. of Pages : 150

Buy Now

Biopsy Devices Market Analysis, Scope, and Growth by 2031

Buy Now

Biopsy Devices Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 2.83 Billion
Market Size by 2031	US$ 4.59 Billion
Global CAGR (2023 - 2031)	6.20%
Historical Data	2021-2022
Forecast period	2023-2031
Segments Covered	By Product Needle-Based Biopsy Localization Wires Procedure Trays By Technology CT Scan Ultrasound-Guided Biopsy Stereotactic-Guided Biopsy MRI-Guided Biopsy By Application Lung Biopsy Kidney Biopsy Liver Biopsy Breast Biopsy
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	BD QIAGEN Hologic Bio Rad Laboratories Cardinal Health Medtronic plc Fujifilm Corporation Cook medical

Biopsy Devices Market News and Recent Developments

The Biopsy Devices Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for Biopsy Devices:

TransMed7, LLC declared a “First in Human” clinical case of the commercial production version of a Heron XPS device. It is a member of the new Heron family of vacuum-assisted, single insertion/multiple collection soft tissue biopsy devices. (Source: Transmed7, Press Release/Company Website/Newsletter, August 2022)
Boston Scientific Corporation announced the U.S. Food and Drug Administration approval for the latest-generation WATCHMAN FLX Pro Left Atrial Appendage Closure (LAAC) Device. Designed to advance further the procedural performance and safety of the WATCHMAN technology, which is indicated to reduce stroke risk in patients with non-valvular atrial fibrillation (NVAF) who need an alternative to oral anticoagulation therapy, the device now features a polymer coating, visualization markers, and a broader size matrix to treat a wider range of patients. (Source: Boston Scientific Corporation, Press Release/Company Website/Newsletter, September 2023)
Mammotome, an operating company of Danaher Corporation, launched the Mammotome RevolveTM EX Dual Vacuum-Assisted Breast Biopsy System. It is the first vacuum-assisted biopsy device designed specifically for the excision of benign breast lesions and is twice as fast as traditional vacuum-assisted breast biopsy systems. This device is a minimally invasive solution and enables physicians to provide better care for patients with benign lesions by avoiding the risks and trauma of an open surgical procedure and creating little to no scarring. (Source: Danaher Corporation, Press Release/Company Website/Newsletter, Aug 2022)

Biopsy Devices Market Report Coverage and Deliverables

The “Biopsy Devices Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Market dynamics such as drivers, restraints, and key opportunities
Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis
Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
Detailed company profiles